Archean Chemical Industries Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹301Cr
- −13% YoY
- +18% QoQ
- Net profit
- ₹12Cr
- −77.8% YoY
- −50% QoQ
- Margin
- 15%
- −11 pp YoY
- −6 pp QoQ
Guidance rank: #56 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time. Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.
From Archean Chemical Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time.
- Industrial Salt business is anticipated to grow at 10%-12% annually, supported by brine field expansion enhancing both salt and liquor production for bromine.
- Bromine derivatives business is scaling up, with volume sales and revenue sharply increasing; focus on product development and capacity utilization improvements.
- SOP business is undergoing reengineering and is expected to scale up production from the second half of the year.
2 more points from Archean Chemical Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.
- A pilot line for wafer manufacturing is under development at IIT Bhubaneshwar through SiCSem, with ongoing capital expenditure under intellectual property development and technology transfer agreements.
- A new area for expanding the brine pond has been established to enhance bromine production capacity, aiming for increased peak production around FY27 or FY28.
2 more points from Archean Chemical Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Archean Chemical Industries Ltd — Quarterly revenue & net profit
Archean Chemical Industries Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 301 | 346 | -13% | 255 | +18% |
| Operating profit (EBITDA) | 44 | 88 | -50% | 54 | -18.5% |
| Operating margin | 15% | 26% | -11 pp | 21% | -6 pp |
| Profit before tax | 16 | 75 | -78.7% | 33 | -51.5% |
| Net profit (PAT) | 12 | 54 | -77.8% | 24 | -50% |
| EPS (₹) | 1.09 | 4.34 | -74.9% | 1.91 | -42.9% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹297 Cr, net profit ₹31 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Archean Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Archean Chemical Industries Ltd Q4 FY26 results?
Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time. Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.
What is Archean Chemical Industries Ltd share price analysis?
Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical Industries Ltd planning capital expenditure?
The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.
Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
